Neoplasms, Colorectal

Explore clinical trials studying Neoplasms, Colorectal. Study availability and eligibility vary by location and protocol.

17 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Neoplasms, Colorectal trial results

Completed

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

NCT00387387

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: GSK Investigational Site Hyderabad, Andhra Pradesh, India

GSK Investigational Site Pārel, India

GSK Investigational Site Cambridge, Cambridgeshire, United Kingdom

GSK Investigational Site Oxford, Oxfordshire, United Kingdom

View Trial Details

Completed

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer

NCT01139138

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Carcinoma, +12 more
Locations: The Queen Elizabeth Hospital Adelaide, South Australia, Australia

View Trial Details

Completed

Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)

NCT01671592

Conditions: Carcinoma, Colonic Diseases, Colorectal Cancer, +15 more
Locations: UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases

NCT00920803

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: GSK Investigational Site Leicester, Leicestershire, United Kingdom

View Trial Details

Completed

Green Tea Extracts for the Prevention of Colorectal Adenomas and Colorectal Cancer

NCT02321969

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +9 more
Locations: Not specified

View Trial Details

Completed

Nelfinavir, a Phase I/Phase II Rectal Cancer Study

NCT00704600

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Carcinoma, +12 more
Locations: Maastro clinic Maastricht, Netherlands

View Trial Details

Completed

A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

NCT00478634

Conditions: Colonic Diseases, Colorectal Cancer, Colorectal Carcinoma, +12 more
Locations: Highlands Oncology Group Fayetteville, Arkansas, United States

Comprehensive nBlood and Cancer Care Bakersfield, California, United States

UCSD - Moores Cancer Center La Jolla, California, United States

Comprehensive Cancer Care Los Angeles, California, United States

View all 16 locations

View Trial Details

Neoplasms, Colorectal

Neoplasms, Colorectal trial results

Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, Oxaliplatin)

Safety Study of the Combination of Panitumumab, Irinotecan and Everolimus in the Treatment of Advanced Colorectal Cancer

Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)

A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases

Green Tea Extracts for the Prevention of Colorectal Adenomas and Colorectal Cancer

Nelfinavir, a Phase I/Phase II Rectal Cancer Study

A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer

Related conditions